Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Prostatic Neoplasms 4Urinary Bladder Neoplasms 2Small Cell Lung Carcinoma 2Precancerous Conditions 2Lung Neoplasms 2Vascular Diseases 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Radiation-induced Injuries in Patients With Rectal Cancer 1Radiation Injuries 1Neurotoxicity Syndromes 1Neoplasms 1Myocardial Ischemia 1Myocardial Infarction 1Heart Diseases 1Head and Neck Neoplasms 1Depression 1Delirium 1Coronary Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1Cerebrovascular Disorders 1Cardiovascular Diseases 1Carcinoma, Non-Small-Cell Lung 1Adenomatous Polyps 1

Interventions

Cisplatin 47Radiotherapy 37Fluorouracil 23Cetuximab 17pembrolizumab 11Carboplatin 11Paclitaxel 8Docetaxel 8Radiotherapy, Intensity-Modulated 6Chemotherapy, Adjuvant 6Surgical Procedures, Operative 5Standard of Care 5nimotuzumab 4Methotrexate 4Gabapentin 4Drug Therapy 4Afatinib 4Radiotherapy, Conformal 3Radiation 3Porfiromycin 3Nivolumab 3Neoadjuvant Therapy 3Fibroblast Growth Factor 7 3Bleomycin 3zalutumumab 2sargramostim 2epacadostat 2Tranexamic Acid 2Tirapazamine 2Pilocarpine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Head and Neck Neoplasms × Vitamin E × Clear all
NCT00054561 2023-06-15

Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Eastern Cooperative Oncology Group

Phase 3 Completed
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡